Overview

Hemostasis (Coagulation) Analyzer Market is estimated to value over USD 6.7 billion by 2027 end with a CAGR of over 9.9% during the forecast period 2020 to 2027.

The rising number of instances of blood related diseases which has led to an increase in the assignment of funds for establishing coagulation analyzers, thus aiding in the growth of the market. Moreover, a growing number of cases associated with cardiovascular and blood disorders along iwht the rising geriatric and obses population which are other important factors responsible for the Conversely, strict regulatory policies pertaining to the validation of medical devices has proven to be an obstacle, especially for new entrants and small scale players, which retraints the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hemostasis (Coagulation) Analyzer Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hemostasis (Coagulation) Analyzer Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Hemostasis (Coagulation) Analyzer Market:

• Alere Inc.
• Nihon Kohden Corporation
• Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
• Siemens Healthcare (A Division of Siemens AG)
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Diagnostica Stago Sas
• Helena Laboratories
• Instrumentation Laboratory (A Division of the Werfen Group)
• International Technidyne Corporation (ITC)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Hemostasis (Coagulation) Analyzer Market Segmentation:

By Product

• Clinical Laboratory Analyzers
• Systems
• Automated Systems
• Semi-automated Systems
• Manual Systems
• Consumables
• Reagents
• Standards, Controls and Calibrations
• Analyzers for Point-of-Care Testing

By Test

• Prothrombin Time
• Fibrinogen
• Activated Partial Thromboplastin Time
• Activated Clotting Time
• D Dimer
• Platelet Function
• Anti-factor Xa
• Heparin & Protamine Dose Response Test for ACT
• Other Coagulation Tests

By Technology

• Mechanical
• Optical
• Electrochemical
• Other Technologies

By End Users

• Clinical Laboratories
• POC
• Others End Users

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Hemostasis (Coagulation) Analyzer Market By Product, By Test, By Technology, By End Users and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
            2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
            2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Hemostasis (Coagulation) Analyzer Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
               5.1.1. Market Driver Analysis
                          5.1.1.1. Increasing focus of Hemostasis (Coagulation) Analyzer Companies on Brand Protection
                          5.1.1.2. Untapped Opportunities in Emerging Regions
               5.1.2. Market Restraint Analysis
                           5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
               5.1.3. Industry Challenges
                           5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Hemostasis (Coagulation) Analyzer Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Hemostasis (Coagulation) Analyzer Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
       7.1. Clinical Laboratory Analyzers
       7.2. Systems
               7.2.1. Automated Systems
               7.2.2. Semi-automated Systems
               7.2.3. Manual Systems
       7.3. Consumables
               7.3.1. Reagents
               7.3.2. Standards, Controls and Calibrations
       7.4. Analyzers for Point-of-Care Testing 

8. Global Hemostasis (Coagulation) Analyzer Market, By Test Historical Analysis and Forecast 2020-2027 (USD Million)
       8.1. Prothrombin Time
       8.2. Fibrinogen
       8.3. Activated Partial Thromboplastin Time
       8.4. Activated Clotting Time
       8.5. D Dimer
       8.6. Platelet Function
       8.7. Anti-factor Xa
       8.8. Heparin & Protamine Dose Response Test for ACT
       8.9. Other Coagulation Tests

9. Global Hemostasis (Coagulation) Analyzer Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
       9.1. Mechanical
       9.2. Optical
       9.3. Electrochemical
       9.4. Other Technologies 

10. Global Hemostasis (Coagulation) Analyzer Market, By End Users Historical Analysis and Forecast 2020-2027 (USD Million)
       10.1. Clinical Laboratories
       10.2. POC
       10.3. Others End Users 

11.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            11.2.1. U.S.A
            11.2.2. Canada
            11.2.3. Mexico
       11.3. Market Size (USD Million) Forecast for North America 2020-2027

12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       12.1. Introduction
       12.2. Regional Market Trends
       12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            12.3.1. Brazil
            12.3.2. Venezuela
            12.3.3. Argentina
            12.3.4. Rest of Latin America
       12.4. Market Size (USD Million) Forecast for Latin America 2020-2027

13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            13.2.1. Germany
            13.2.2. U.K
            13.2.3. France
            13.2.4. Italy
            13.2.5. Spain
            13.2.6. Russia
            13.2.7. Poland
            13.2.8. Switzerland
            13.2.9. Rest of Western Europe

14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       14.1. Introduction
       14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             14.2.1. Japan
             14.2.2. China
             14.2.3. Singapore
             14.2.4. India
             14.2.5. Australia and New Zealand
             14.2.6. ASEAN
             14.2.7. South Korea
             14.2.8. Rest of Asia Pacific
       14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       15.1. Introduction
       15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             15.2.1. Saudi Arabia
             15.2.2. UAE
             15.2.3. South Africa
             15.2.4. Egypt
       15.3. Market Size (USD Million) Forecast for MEA 2020-2027

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       16.1. Alere Inc.
                16.1.1. Company Overview
                16.1.2. Product Portfolio
                16.1.3. SWOT Analysis
                16.1.4. Financial Overview
                16.1.5. Strategic Overview
       16.2. Nihon Kohden Corporation
                16.2.1. Company Overview
                16.2.2. Product Portfolio
                16.2.3. SWOT Analysis
                16.2.4. Financial Overview
                16.2.5. Strategic Overview
       16.3. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
                16.3.1. Company Overview
                16.3.2. Product Portfolio
                16.3.3. SWOT Analysis
                16.3.4. Financial Overview
                16.3.5. Strategic Overview
       16.4. Siemens Healthcare (A Division of Siemens AG)
                16.4.1. Company Overview
                16.4.2. Product Portfolio
                16.4.3. SWOT Analysis
                16.4.4. Financial Overview
                16.4.5. Strategic Overview
       16.5. Sysmex Corporation
                16.5.1. Company Overview
                16.5.2. Product Portfolio
                16.5.3. SWOT Analysis
                16.5.4. Financial Overview
                16.5.5. Strategic Overview
       16.6. Thermo Fisher Scientific Inc.
                16.6.1. Company Overview
                16.6.2. Product Portfolio
                16.6.3. SWOT Analysis
                16.6.4. Financial Overview
                16.6.5. Strategic Overview
       16.7. Diagnostica Stago Sas
                16.7.1. Company Overview
                16.7.2. Product Portfolio
                16.7.3. SWOT Analysis
                16.7.4. Financial Overview
                16.7.5. Strategic Overview
       16.8. Helena Laboratories
                16.8.1. Company Overview
                16.8.2. Product Portfolio
                16.8.3. SWOT Analysis
                16.8.4. Financial Overview
                16.8.5. Strategic Overview
       16.9. Instrumentation Laboratory (A Division of the Werfen Group)
                16.9.1. Company Overview
                16.9.2. Product Portfolio
                16.9.3. SWOT Analysis
                16.9.4. Financial Overview
                16.9.5. Strategic Overview
       16.10. International Technidyne Corporation (ITC) 
                16.10.1. Company Overview
                16.10.2. Product Portfolio
                16.10.3. SWOT Analysis
                16.10.4. Financial Overview
                16.10.5. Strategic Overview

17. FutureWise SME key takeaway points for Client

Tables

Figures